No Data
No Data
Revolution Medicines(RVMD.US) Officer Sells US$299.94K in Common Stock
$Revolution Medicines(RVMD.US)$ Officer GOLDSMITH MARK A sold 7,500 shares of common stock on Jun 3, 2024 at an average price of $39.9923 for a total value of $299.94K.Source: Announcement What is sta
Revolution Medicines Insider Sold Shares Worth $299,942, According to a Recent SEC Filing
Mark A Goldsmith, Director, President and Chief Executive Officer, on June 03, 2024, sold 7,500 shares in Revolution Medicines (RVMD) for $299,942. Following the Form 4 filing with the SEC, Goldsmith
Revolution Medicines to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
Revolution Medicines, Inc. (Nasdaq: RVMD) today announced that Mark A. Goldsmith, M.D., Ph.D., the company's chief executive officer and chairman, will be a featured speaker in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference.
Form 144 | Revolution Medicines(RVMD.US) Director Proposes to Sell 287.48K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 3, $Revolution Medicines(RVMD.US)$、$REVOLUTION MEDICINES INC C/WTS (TO PUR COM)(RVMDW.US)$ Director MARK A GOLDSMITH TODSUBJECT TO STA RULES intends to sell 7,500 shares of
Viking, CRISPR, Intellia Among Potential M&A Targets: Wells Fargo
Revolution Medicines(RVMD.US) Officer Sells US$58,670.87 in Common Stock
$Revolution Medicines(RVMD.US)$ Officer Cislini Jeff sold 1,500 shares of common stock on May 21, 2024 at an average price of $39.1139 for a total value of $58,670.87.Source: Announcement What is stat